BioCardia, Inc. Current Assets
BioCardia, Inc. (BCDA) had Current Assets of $4.30 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $4.30M.
- 2026-03-31: Assets, Current $1.14M.
- 2025-12-31: Assets, Current $2.73M.
- 2025-09-30: Assets, Current $5.37M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $4.30M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.14M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.73M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $5.37M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.20M 10-Q/A · filed 2025-10-29 |
| 2025-03-31 | $1.17M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.62M 10-K · filed 2026-03-24 |
| 2024-09-30 | $5.06M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.57M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.26M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.46M 10-K · filed 2025-03-26 |
| 2023-09-30 | $2.12M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.65M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $5.29M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $7.86M 10-K · filed 2024-03-27 |
| 2022-09-30 | $7.15M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $9.15M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $10.66M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $13.48M 10-K · filed 2023-03-29 |
| 2021-09-30 | $17.01M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $19.74M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $22.66M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $22.66M 10-K · filed 2022-03-29 |
| 2020-09-30 | $8.59M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $12.10M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $3.22M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $6.38M 10-K · filed 2021-03-30 |
| 2019-09-30 | $9.24M 10-Q · filed 2019-11-19 |
| 2019-06-30 | $1.15M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $3.53M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $6.22M 10-K · filed 2020-04-09 |
| 2018-09-30 | $5.35M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $7.44M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $10.21M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $13.31M 10-K · filed 2019-04-02 |
| 2017-09-30 | $15.64M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $17.52M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $19.55M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $21.92M 10-K · filed 2018-03-16 |
| 2015-12-31 | $4.67M 10-K · filed 2017-03-30 |
| 2012-12-31 | $13.30M 10-K · filed 2013-03-22 |
| 2011-12-31 | $13.73M 10-K · filed 2013-03-22 |
| 2011-09-30 | $14.00M 10-Q · filed 2011-11-15 |
| 2011-06-30 | $14.65M 10-Q/A · filed 2011-11-17 |
| 2010-12-31 | $639.00K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |